SUMMARY
T he BB rat is prone to the spontaneous development of insulin-dependent diabetes mellitus (IDDM), and has become a widely studied animal model of human IDDM. 1 Around the age of sexual maturation (60-120 days), 40-60% of the rats became diabetic, manifesting hyperglycemia, hypoinsulinemia, and ketoacidosis that is lethal if insulin is not administered. Histologic study of acutely diabetic BB rats reveals intense infiltration of pancreatic islets (insulitis) by mononuclear cells, 2 mostly lymphocytes and macrophages, 3 and chronically diabetic animals have islets devoid of beta cells. 4 The observation of insulitis suggests a cell-mediated immune pathogenesis for diabetes in the BB rat. This concept is supported by the demonstration that concanavalin A (Con A)-activated splenic lymphoid cells from acutely diabetic BB/W rats can transfer disease to young diabetes-prone BB/W rats, 5 and to immunosuppressed inbred Wistar-Furth rats 6 and diabetes-resistant BB/W control rats. Production of diabetes by adoptive transfer of spleen cells from diabetic to nondiabetic animals is not definitive evidence that the donor cells were directly responsible for the beta cell damage. Interactions of the transplanted cells with the recipient's own immune system might indirectly account for the diabetic state produced in the recipient animal. In this study we have obtained direct evidence for anti-islet cellular immunity in diabetic BB rats. Splenic lymphoid cells, cytotoxic to rat islet cells and to a rat insulinoma cell line, were detected in diabetic and in diabetes-prone BB/W rats, and these cellular immune responses were further characterized in vitro.
MATERIALS AND METHODS

Animals.
Female BB/W rats were obtained from the colony maintained at the University of Massachusetts Medical School, Worcester, Massachusetts (Dr. A. A. Like). These animals have an expected frequency of diabetes of 40-60% between 60 and 120 days of age. Rats were defined as diabetic if their urine glucose was 2-4 + with Tes-Tape (Eli Lilly and Company, Indianapolis, Indiana) and plasma glucose concentrations exceeded 200 mg/dl. Diabetic (D) rats were treated with a single daily injection of 1-2 U of protamine zinc insulin and were studied within 12 days of diagnosis. Diabetes-prone (DP) rats were obtained from the same BB/ W sublines as the diabetic animals (17-20 generations of brother-sister matings) and were studied at 100-130 days rON. AND A. RABINOV of age. Diabetes-resistant (DR) rats were age matched to the DP rats and obtained from BB/W sublines bred for resistance to diabetes. Splenic lymphoid cell preparations. Spleens were removed aseptically from anesthetized rats (sodium pentobarbital, 50 mg/kg body wt) and washed twice in serum-free RPMI 1640 medium (Gibco Laboratories, Grand Island, New York) supplemented with 100 U/ml penicillin and 100 |xg/ml streptomycin. Each spleen was then disrupted in a glass homogenizer, the cell suspension filtered through sterile gauze, and transferred to a 50-ml polypropylene centrifuge tube in a final volume of 35 ml. Then 15 ml of Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, New Jersey) was layered underneath the spleen cells and the cells were centrifuged at 400 g for 30 min. Lymphoid (mononuclear) cells were collected from the interface, washed twice, resuspended in RPMI medium further supplemented (complete medium) with 10% heat-inactivated fetal calf serum (Gibco), counted, and adjusted to the desired concentrations for use as effector cells in the cytotoxicity assays. For some experiments, the splenic lymphoid cells were incubated (5 x 10 6 / ml) at 37°C in 95% humidified air:5% of CO 2 for 2 days in complete medium either without or with 5 jig/ml concanavalin A (Sigma Chemical Co., St. Louis, Missouri) before use as effector cells in the cytotoxicity assays. Beta cell destruction assays. Islets were isolated from 125-150-g female Wistar-Furth rats, MHC-compatible (RTI U ) with the BB/W rats, by the collagenese digestion method. 8 The islets were dissociated into single cells by incubation in Ca 2+ /Mg 2+ -free phosphate-buffered saline (PBS) with 3 mM EGTA at 37°C for 10 min, then in PBS with 1 mg/ml trypsin at 37°C for 10 min. 9 Islet cells (25,000/well in 0.2 ml complete medium) were seeded in a 96-well microculture plate (Costar, Cambridge, Massachusetts) and incubated at 37°C in the CO 2 incubator for 3 days to allow cells to attach and to form a monolayer. RIN islet cell monolayers (25,000 cells/well) were prepared as previously described. 10 The RIN cell line (clone 5F) is derived from the NEDH (RT1 9 ) rat islet cell tumor and synthesizes and secretes primarily insulin. 11 Cytotoxic effects of splenic lymphoid cells from BB/W rats on the WF rat and RIN islet cell cultures were evaluated by incubating the lymphoid cells (500,000/well, 6 replicates) in 0.2 ml complete medium at 37°C for 2 days with the freshly washed islet monolayer cultures. The medium was then aspirated from the cultures, the cells were washed 3 times, and incubated in acid-ethanol (75% ethanol, 1.5% 12 M HCI, 23.5% H 2 O) at 4°C for 12 h to extract insulin from the cells. Insulin, measured by radioimmunoassay, 12 served as a measure of beta cell survival in the cultures. Cr sodium chromate (New England Nuclear, Boston, Massachusetts) in 0.3 ml complete medium for 90 min at 37°C, washed 3 times, resuspended to 0.5 x 10 6 /ml, and seeded at 25,000 cells per well in a 96-well one-half area microculture plate (Costar). Splenic effector cells from BB/W rats were added in volumes of 0.1 ml (4 replicate wells) to give the desired target:effector cell ratio. The plates were centrifuged (100 x g for 3 min) and incubated at 37°C for 8 h. An aliquot (0.1 ml) was removed from each well and counted in a gamma counter. Total 51 Cr release was determined by adding 0.1 ml of 4% Triton X-100 to a set of target cells. Release of 51 Cr in the absence of effector cells (spontaneous release) was <10% of total 51 Cr release. Specific cytotoxicity was calculated from the following formula: %lysis = 100 x (test cpm -spontaneous cpm) H-(total cpm -spontaneous cpm). Figure 1 shows the destruction of RIN islet cell monolayers by splenic lymphoid cells from D rats, and to a lesser extent BB/W rat splenic lymphoid cells (500,000/well) were incubated for 2 days with monolayer cultures of WF rat islet cells (25,000/well) or cells from a rat islet cell line (RIN 5F, 25,000/well). Medium was removed and the cells were washed and extracted in acid ethanol for assay of insulin content. *Mean ± SEM ng insulin/well for numbers of BB/W rats shown in parentheses. |P < 0.01, +P < 0.025 compared with no spleen cells added (Student's f-test).
RESULTS
by splenic lymphoid cells from DP rats, compared with the lack of any destructive effects to the RIN cells by splenic lymphoid cells from DR rats. Cytotoxic effects to beta cells in the RIN islet cell cultures and also to beta cells in WF rat islet cultures were measured as a decrease in insulin content in the cultures (Table 1) . Insulin contents in WF rat islet cell cultures were significantly decreased in the presence of D (-32%) and DP (-20%) spleen cells, whereas DR spleen cells had no significant effects. Similarly, insulin contents in RIN islet cell cultures were significantly decreased in the presence of D (-77%) and DP (-63%) spleen cells, whereas DR spleen cells had no significant effects.
The destructive effects of D and DP rat splenic lymphoid cells on RIN islet cells were detected also by the release of of 1:20, lysis (mean ± SEM) of RIN cells by D cells (21.6 ±2.0%, P < 0.001) and by DP cells (16.5 ±4.1%, P < 0.001) was significantly greater than by DR cells (5.4 ± 1.0%). Also, at a target:effector cell ratio of 1:8, lysis of RIN cells by D cells (12.5 ± 2.4%, P < 0.005) and by DP cells (10.9 ± 1.6%, P < 0.01) was significantly greater than by DR cells (2.4 ± 1.2%). At a target:effector cell ratio of 1:2, the differences between the effects of D, DP, and DR cells were not significant.
Since the priming of diabetic BB/W rat splenic lymphoid cells with the lymphocyte mitogen concanavalin A (Con A) in vitro has been reported to confer to the cells the ability to adoptively transfer diabetes in vivo, 5 " 7 we tested the ability of Con A-primed splenic lymphoid cells from diabetic rats to deliver increased cytotoxicity to islet cells in our in vitro assay. Table 2 shows that splenic lymphoid cells primed with Con A for 2 days were significantly more cytotoxic to RIN islet cells than were unprimed cells; increases (mean ± SEM) in cytotoxicity after Con A priming were 96 ± 18% (P < 0.01) for D cells, 116 ± 3 9 % (P < 0.025) for DP cells, and 74 ± 28% (P < 0.05) for DR cells. Table 2 also shows that lysis of the rat pituitary cell line (GH 3 ) was low and similar when using D, DP, and DR splenic cells as effectors, either unprimed or Con A primed, in contrast to the differences observed between D, DP, and DR splenic effectors using RIN islet cells as targets. BB/W rat splenic lymphoid cells were incubated for 2 days in the absence (unprimed) or presence of 5 jig/ml concanavalin A (Con A-primed), washed, then incubated as effector cells (500,000/well) for 8 h with target cells (25,000/well) from a rat islet cell line (RIN 5F) or a rat pituitary cell line (GH 3 ). *Mean ± SEM percent specific 51 Cr release for numbers of BB/W rats shown in parentheses. f P < 0 . 0 1 , ±P < 0.025, §P < 0.05 compared with effects on RIN targets of unprimed cells from corresponding rats (Student's r-test for paired samples).
immune response to islets in another animal model of diabetes, the mouse made diabetic with multiple low doses of streptozocin, islet-specifio cytotoxic cells in the spleen of these diabetic mice were demonstrated in vitro, by using RIN islet cells as targets. 15 In another study in the BB/W rat, both MHC-compatible and MHC-incompatible rat isolated islet grafts revealed lymphocytic insulitis after transplantation into diabetes-prone BB/W rats. 16 Also, insulitis in the islet grafts was almost always concordant with insulitis in the pancreas and the appearance of diabetes in the diabetes-prone islet recipient. The results of our experiments support these findings by showing that otherwise normal, MHC-compatible islet cells are killed by BB/W D and DP splenic lymphoid cells in vitro and that these lymphoid cells also are cytotoxic to non-MHC-compatible RIN islet cells.
Detection of islet-directed cytotoxicity in DP BB/W rats in the present study suggests that the cytotoxic cells may predispose to, rather than be a consequence of, the diabetic state. Indeed, although not hyperglycemic or glucosuric, DP BB rats may reveal glucose intolerance and insulitis. 1 We are presently assessing young DP BB/W rats to determine whether islet-directed cytotoxicity measured in vitro may be predictive of diabetes in individual animals.
The present demonstration that islet-directed cytotoxic effects could be increased significantly by first stimulating the diabetic spleen cells with Con A for 2 days in vitro is in accord with reports that activation of diabetic BB/W splenic lymphocytes with Con A is required to confer to these cells the ability to adoptively transfer diabetes in vivo. 5 * 7 Therefore, the in vitro assays for islet-directed lymphoid cell-mediated cytotoxicity described in the present study complement the passive transfer in vivo assays and should facilitate further investigations of the identity of the cytotoxic lymphoid cells and how these cells act to produce beta cell destruction.
